[ad_1]
Dublin, 05 May 2020 (GLOBE NEWSWIRE) – Added report “Biopharmaceutical Contract Manufacturing Market until 2027 – Global Analysis and Forecasts by Product, Service and Geography” ResearchAndMarkets.com’s offering.
The contract manufacturing market for biopharmaceuticals was valued at $ 13,727.13 million in 2019 and is expected to grow at an annual compound rate of 8.2% from 2020 to 2027 to reach $ 25,497.26 million in 2027.
The drivers of the contract manufacturing market for biopharmaceuticals are the increasing trend of outsourcing among pharmaceutical companies and the increased demand for organic products. However, increasing competition in the biopharmaceutical contract manufacturing industry is hampering market growth.
The contract manufacturing organization (CMO) offers numerous benefits, including reduced facility investments and drug development costs, to pharmaceutical companies, thereby improving net cash flow. Outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it enables pharmaceutical and biotech companies to redirect resources to other areas. A few years ago, the CMO industry was a service market niche, offering additional manufacturing capacity or specific services to pharmaceutical companies. Today, many pharmaceutical and biotech companies outsource various services, from early stage drug development to commercial scale manufacturing. As the pharmaceutical industry is shifting from large-scale production to more specific and targeted therapies (personalized medicine), the demand for flexible operating capabilities, production scales, and multi-product operations is leading to an increased inclination toward CMO.
The global contract manufacturing market for biopharmaceuticals is segmented into products and services. The contract manufacturing market for biopharmaceuticals, by product, is segmented into biological and biosimilar products. The organic products segment had the largest market share in 2019, while the biosimilar segment is expected to record the highest CAGR on the market during the forecast period. Depending on the services, the market is segmented into development processes, final dosing operations and final packaging. The development process had the highest market share in 2019, while the analytical and quality control segment is estimated to record the highest CAGR on the market during the forecast period.
Some of the essential primary and secondary sources included in the report are the Pharmacy and Biopharmacy Outsourcing Association (PBOA), the Centers for Disease Control and Prevention and the Organization for Economic Cooperation and Development.
Reasons to buy:
- Save and reduce time by conducting entry-level research by identifying growth, size, key players and segments in the biopharmaceutical contract manufacturing market.
- Highlights key business priorities to help companies realign their business strategies.
- The key findings and recommendations highlight crucial industry trends in the global biopharmaceutical contract manufacturing market, enabling value chain actors to develop effective long-term strategies.
- Develop / modify business expansion plans by using a substantial growth offering in developed and emerging markets.
- Take an in-depth look at global market trends and prospects along with the factors that drive the market as well as those that hinder it.
- Enhance the decision-making process by understanding the strategies that underpin the security interest regarding customer products, segmentation, pricing, and distribution.
Key topics covered:
1. Introduction
2. Biopharmaceutical Contract Manufacturing Market: Key Findings
3. Research methodology
4. Biopharmaceutical contract manufacturing: market overview
4.1 General Description
4.2 Pest analysis
4.3 Expert opinion
5. Contract Manufacturing Market for Biopharmaceutical Products – Industry Dynamics
5.1 Key Drivers
5.1.1 Increased outsourcing of pharmaceutical companies
5.1.2 Increasing demand for organic products
5.2 Key market constraints
5.2.1 Increased competition in the industry
5.3 Key market opportunities
5.3.1 Emerging markets
5.4 Future trends
5.4.1 Consolidation in the pharmaceutical industry of OCM
5.5 Impact analysis
6. Biopharmaceutical Contract Manufacturing Market: Global Analysis
6.1 Analysis and global forecast of biopharmaceutical contract manufacturing market revenue
6.2 Global biopharmaceutical contract manufacturing market, by geography: forecast and analysis
6.3 Market positioning of key players
6.3.1 Lonza Group AG
6.3.2 Thermo Fisher Scientific, Inc.
7. Analysis of the contract manufacturing market for biopharmaceutical products: by product
7.1 Overview
7.2 Share of revenue from the contract manufacturing market for biopharmaceuticals, by product (2019 and 2027)
7.3 Organic products
7.3.1 General description
7.3.2 Organic Products – Contract Manufacturing Market for Biopharmaceuticals – Revenue and Forecast for 2027 (US $ million)
7.3.3 Monoclonal Antibodies
7.3.3.1 General description
7.3.3.2 Monoclonal Antibodies: Contract Manufacturing Market for Biopharmaceuticals – Revenue and Forecast for 2027 (US $ Million)
7.3.4 Recombinant proteins
7.3.4.1 General description
7.3.4.2 Recombinant proteins: contract manufacturing market for biopharmaceuticals: revenue and forecast for 2027 (US $ million)
7.3.5 Vaccines
7.3.5.1 General description
7.3.5.2 Vaccines: contract manufacturing market for biopharmaceutical products: revenue and forecast for 2027 (US $ million)
7.3.6 Others
7.3.6.1 General description
7.3.7 Others: contract manufacturing market for biopharmaceutical products: revenue and forecast for 2027 (US $ million)
7.4 Biosimilars
7.4.1 General description
7.4.2 Biosimilars: contract manufacturing market for biopharmaceuticals: revenue and forecast for 2027 (US $ million)
8. Contract manufacturing market for biopharmaceutical products: by service
8.1 General Description
8.2 Contract manufacturing market for biopharmaceutical products, by service, 2019 and 2027 (%)
8.3 Development process
8.3.1 General description
8.3.2 Development process: Contract manufacturing market for biopharmaceutical products: revenue and forecast for 2027 (US $ million)
8.4 Final dosing operation
8.4.1 General description
8.4.2 Final dosing operation: contract manufacturing market for biopharmaceuticals: revenue and forecast for 2027 (US $ million)
8.5 Analytical and quality control
8.5.1 General description
8.5.2 Analytical and quality control: contract manufacturing market for biopharmaceuticals: revenue and forecast for 2027 (US $ million)
8.6 Final packaging
8.6.1 General description
8.6.2 Final packaging: contract manufacturing market for biopharmaceuticals: revenue and forecast for 2027 (US $ million)
9. Biopharmaceutical Contract Manufacturing Market: Geographical Analysis
9.1 North America: biopharmaceutical contract manufacturing market
9.2 Europe: biopharmaceutical contract manufacturing market
9.3 Asia Pacific: biopharmaceutical contract manufacturing market
9.4 Middle East and Africa: biopharmaceutical contract manufacturing market
9.5 South and Central America: biopharmaceutical contract manufacturing market
10. Impact of the COVID-19 pandemic on the biopharmaceutical contract manufacturing market
10.1 North America: Impact Assessment of the COVID-19 Pandemic
10.2 Europe: Impact assessment of the COVID-19 pandemic
10.3 Asia-Pacific: Impact Assessment of the COVID-19 Pandemic
10.4 Rest of the world: impact assessment of the COVID-19 pandemic
11. Biopharmaceutical Contract Manufacturing Market: Industry Overview
11.1 Overview
11.2 Growth strategies carried out by companies in the market, (%)
11.3 Organic developments
11.3.1 General Description
11.4 Inorganic developments
11.4.1 General description
12. Company profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key facts
12.1.2 Description of the business
12.1.3 Products and services
12.1.4 Financial summary
12.1.5 SWOT Analysis
12.2 THERMO FISHER SCIENTIFIC INC.
12.3 General Electric Company
12.4 MERCK KGAA
12.5 Lonza
12.6 Samsung Biologics.
12.7 AbbVie Inc.
12.8 WUXI BIOLOGY
12.9 Ajinomoto Co. Inc.
12.10 Inno Bio Ventures Sdn Bhd
13. Appendix
13.1 About the editor
13.2 Glossary of terms
For more information on this report, visit https://www.researchandmarkets.com/r/r4083n
Research and Markets also offers personalized research services that provide focused, comprehensive and personalized research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
